Dr. Drew Weissman, a member of Arcturus Therapeutics’ Scientific Advisory Board, Received 2023 Nobel Prize in Physiology or Medicine
We are honored to announce that Dr. Drew Weissman, a member of Arcturus Therapeutics’ Scientific Advisory Board, was awarded the 2023 Novel Prize in Physiology or Medicine with Dr. Katalin Karikó “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.”
Please refer to the official website of the Nobel Prize; https://www.nobelprize.org/prizes/medicine/
ARCALIS is an mRNA medicine contract manufacturing and development (“mRNA medicine CDMO”) business established in 2021. ARCALIS is aiming to develop the world’s first integrated mRNA medicine CDMO business being able to provide stable supply of high-quality mRNA medicines to a wide range of customers based on Arcturus Therapeutics’ next generation mRNA platform technology.